MedTrace Logo

Does the VTS1000 Infra Red Vein Imager Allow Better Identification of Veins Than Normal Eyesight?

NCT01138228 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2010-06-07

No results posted yet for this study

Summary

VueTek has developed a head mounted device that will improve the viewing of superficial, subcutaneous vasculature, differentiating it with higher contrast from surrounding tissue. Video of the vasculature is displayed to the user in a portable headset. The headset and display combination facilitates both visualization in the display and an open field of view directly to the subject's anatomy and practitioner's surroundings. The goal is to provide a non-diagnostic, enhanced visual aide that is used alongside standard visual and tactile methodology. The primary and secondary objectives of this validation are as follows:

1. Primary Objective:

To demonstrate that the VTS1000 affords visualization of superficial, subcutaneous vascular structures, when compared to the naked eye.
2. Secondary Objective:

To demonstrate that the VTS1000 enhances visualization of superficial, subcutaneous vascular structures over the naked eye.

Validation Ancillary Endpoints

1\. To gather data to demonstrate that the VTS1000 is portable, affords conventional vascular access methods, and provides flexibility, fit and balance during use.

Conditions

  • Vision

Sponsors & Collaborators

  • Vue Tek Scientific

    collaborator UNKNOWN

  • St. Luke's-Roosevelt Hospital Center

    lead OTHER

Principal Investigators

  • Franco Resta-Flarer, M.D. · St. Luke's Roosevelt Hospitals

Eligibility

Min Age
4 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01138228 on ClinicalTrials.gov